Scholarlink

<p>Radiotherapy effectively treats colorectal cancer (CRC), but local recurrence remains common and abscopal effects—regression of tumors distant from irradiated sites—are rarely observed even with immune checkpoint inhibitors. Here we show that the protein kinase NEK8, highly expressed in CRC, promotes radioresistance by suppressing anti-tumor immunity. In radiation-resistant tumors, NEK8 phosphorylates lactate dehydrogenase A (LDHA), driving lactate overproduction. This metabolite promotes histone modifications that silence antigen presentation machinery, while extracellular lactate directly impairs CD8<sup>+</sup> T cell function, collectively excluding CD8<sup>+</sup> T cell from the tumor microenvironment. Pharmacological inhibition of NEK8 using CX6258 restores CD8<sup>+</sup> T cell infiltration and enhances both local and systemic tumor control following radiotherapy. These findings establish NEK8 as a promising therapeutic target for overcoming radioresistance and inducing abscopal responses in CRC.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

NEK8 kinase-mediated lactate increase impairs antitumor immunity decreasing radiotherapy sensitivity in colorectal cancer

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2026年3月28日

查看全文
  • Mingzhou Li,
  • Yunfei Ni,
  • Jieqiong Wu,
  • Xin Zou,
  • Yining Chen,
  • Junfeng Qiu,
  • Yifang Li,
  • Huayu Cai,
  • Li Wang,
  • Feifei Wang,
  • Hongxia Zhang,
  • Fangyi Han,
  • Jinghao Huang,
  • Zilong Chen,
  • Bingyu Xu,
  • Li Liang

摘要

Radiotherapy effectively treats colorectal cancer (CRC), but local recurrence remains common and abscopal effects—regression of tumors distant from irradiated sites—are rarely observed even with immune checkpoint inhibitors. Here we show that the protein kinase NEK8, highly expressed in CRC, promotes radioresistance by suppressing anti-tumor immunity. In radiation-resistant tumors, NEK8 phosphorylates lactate dehydrogenase A (LDHA), driving lactate overproduction. This metabolite promotes histone modifications that silence antigen presentation machinery, while extracellular lactate directly impairs CD8+ T cell function, collectively excluding CD8+ T cell from the tumor microenvironment. Pharmacological inhibition of NEK8 using CX6258 restores CD8+ T cell infiltration and enhances both local and systemic tumor control following radiotherapy. These findings establish NEK8 as a promising therapeutic target for overcoming radioresistance and inducing abscopal responses in CRC.